Di Silverio F, Sciarra A, Monti S, Casale P, Seccareccia F
Department of Urology U. Bracci and II Endocrinology, University La Sapienza, Istituto Superiore di Sanita, Rome, Italy.
J Urol. 1999 Jan;161(1):128-32. doi: 10.1097/00005392-199901000-00041.
Except for prostate volume, little is known about the factors influencing serum prostate specific antigen (PSA) levels. Considering that dihydrotestosterone and epidermal growth factor are regulators of the proliferation and differentiation in the epithelial component of human prostate tissue and that PSA is produced only by the epithelial cells of the gland, studies were performed on patients with a histological diagnosis of benign prostatic hyperplasia (BPH) to establish whether a significant association exists between the intraprostatic concentration of dihydrotestosterone or epidermal growth factor and serum PSA levels.
A total of 20 patients with BPH who had not been previously treated were part of a larger study on the correlation among PSA, prostate volume and age, and were evaluated according to the algorithm in the guidelines of the international consultation on BPH. All men underwent open suprapubic prostatectomy to enucleate the entire adenoma and in each case sections were made in the periurethral, subcapsular and intermediate zones of the BPH tissue. Dihydrotestosterone and epidermal growth factor concentrations were evaluated by radioimmunoassay in the periurethral zone and in total BPH tissue.
In these 20 patients with BPH serum PSA levels were significantly associated with epidermal growth factor but not with dihydrotestosterone concentrations in total BPH tissue (r = 0.7762, p = 0.00002836 and r = 0.3923, p = 0.0956307, respectively). A stronger association was found between PSA levels and the periurethral concentration of epidermal growth factor and dihydrotestosterone (r = 0.8117, p = 0.000005 and r = 0.5656, p = 0.0098326, respectively). On the contrary, epidermal growth factor and dihydrotestosterone were not significantly associated with prostate volume (p = 0.957415 and p = 0.531439, respectively).
To our knowledge this study is the first report in the literature to demonstrate an association between serum PSA, and dihydrotestosterone and epidermal growth factor levels, particularly in the periurethral zone of human BPH tissue. These data suggest the importance of epidermal growth factor and dihydrotestosterone in influencing serum PSA levels.
除前列腺体积外,关于影响血清前列腺特异性抗原(PSA)水平的因素知之甚少。鉴于双氢睾酮和表皮生长因子是人类前列腺组织上皮成分增殖和分化的调节因子,且PSA仅由前列腺上皮细胞产生,因此对组织学诊断为良性前列腺增生(BPH)的患者进行了研究,以确定前列腺内双氢睾酮或表皮生长因子浓度与血清PSA水平之间是否存在显著关联。
共有20例未经治疗的BPH患者参与了一项关于PSA、前列腺体积和年龄相关性的更大规模研究,并根据BPH国际咨询指南中的算法进行评估。所有男性均接受耻骨上开放性前列腺切除术以摘除整个腺瘤,并且在每种情况下,均在BPH组织的尿道周围、包膜下和中间区域制作切片。通过放射免疫分析法评估尿道周围区域和整个BPH组织中的双氢睾酮和表皮生长因子浓度。
在这20例BPH患者中,血清PSA水平与整个BPH组织中的表皮生长因子显著相关,但与双氢睾酮浓度无关(r分别为0.7762,p = 0.00002836和r = 0.3923,p = 0.0956307)。在PSA水平与尿道周围表皮生长因子和双氢睾酮浓度之间发现了更强的关联(r分别为0.8117,p = 0.000005和r = 0.5656,p = 0.0098326)。相反,表皮生长因子和双氢睾酮与前列腺体积无显著关联(p分别为0.957415和0.531439)。
据我们所知,本研究是文献中首次报道血清PSA与双氢睾酮和表皮生长因子水平之间存在关联,特别是在人类BPH组织的尿道周围区域。这些数据表明表皮生长因子和双氢睾酮在影响血清PSA水平方面的重要性。